1. Alguna cosa no ha funcionat
  2. Hi ha hagut un error. Si us plau, refresqueu.
Empreses emergents
2009
TRANSMURAL BIOTECH SLTecnologies mèdiques basades en el diagnòstic d'imatge mitjançant la intel·ligència artificial Compromesos amb un diagnòstic clínic personalitzat, predictiu, no invasiu, ràpid i fiable
Adreça
Carrer de Beethoven 15, 08021 Barcelona, Espanya
Xarxes socials

Altres accionistes públics catalans

Logotip

Àrees d'estat i deeptech

Estat de l'empresa i àrees de tecnologia profunda de l'empresa

Estat de l'empresa

Estat de l'empresa

Àrea DeepTech

Àrea DeepTech

Informació sobre la spin-off

Descripció de l'empresa

Our expertise focuses on developing innovative medical technologies, based on image analysis and processing, to provide health professionals with additional information that current technologies cannot provide and substantially improve the quality of service they can offer the patient.

In 2019, we received three outstanding awards in the field of biotechnology: we entered the ranking of the 20 most innovative companies in the world according to «Technology Innovators», we are one of the most relevant digital companies according to «The Silicon Review» and we received the award to the most promising Innovation in Digital Medicine granted by NODE.Health. Before the achievement of these awards, PWC valued the company at 68 million euros.

Descripció del producte

quantusFLM - Transmural Biotech has developed the first 100% non-invasive fetal lung maturity test, based on the analysis of an ultrasound image of the fetal lungs. It is an alternative to amniocentesis, easy to use and offers reliable results in a few minutes.
quantusPREMATURITY - Thanks to our work in R&D, we have developed the first robust test for an early detection of the spontaneous premature birth risk. By analyzing an ultrasound image of the cervix, we can detect cervical remodeling early. Thus, in a fast and reliable way, we provide the opportunity to obtain the risk of spontaneous premature birth.